1 Reason Lemonade Stock Is a Screaming Buy, and 1 Reason to Avoid It Like the Plague
Lemonade (NYSE: LMND) shares have been under immense pressure recently, down 40% since the start of August (as of Aug. 24). This downward trend was propelled by a second-quarter earnings announcement that wasn't well received by shareholders.
The insurance stock currently trades at a price-to-sales ratio of 2.6. That's close to as cheap as they've ever been, so investors might be intrigued by the opportunity to buy a company focused on artificial intelligence (AI).
Let's take a look at one compelling reason that investors should buy Lemonade stock, as well as one reason to avoid it.
Source Fool.com